Sever Pharma Solutions


Sever Pharma Solutions is a dedicated CDMO specializing in high potent drug development, controlled-release systems, and polymer-based delivery solutions. With a history dating back to the 1970s, the company offers end-to-end services including formulation development, manufacturing, and research, with facilities in Malmö, Sweden, and Putnam, CT, USA. They focus on innovative pharmaceutical solutions to improve drug stability, efficacy, and patient outcomes, and are recognized for their advancements in controlled-release systems and high-potent drug manufacturing.

Industries

Pharmaceutical Manufacturing

Nr. of Employees

medium (51-250)

Sever Pharma Solutions


Patents

Drug delivery system for one or more active ingredients

US-11975165-B2

View Details

Intrauterine device, and a method of reducing the rate of diffusion of active ingredients in said intrauterine device

US-11872284-B2

View Details

Intrauterine device and method for reducing the rate of diffusion of active ingredients in said device by adding inert particulates to a polymeric coating

US-9775905-B2

View Details

Products

Polymer-based implants and inserts (controlled release)

Implantable and insertable polymer-based drug delivery systems designed for long-acting, controlled release of potent APIs.

Vaginal rings (controlled-release)

Polymer-based intravaginal rings configured for sustained release of APIs for local or systemic prophylactic or therapeutic use.

Pre-filled syringes and auto-injector assemblies

Aseptically filled pre-filled syringes and assembled auto-injectors for high-potent injectable drugs, with integrated assembly and packaging services.

Solid oral dosage forms manufactured via HME

Oral tablets and capsules produced from hot melt extruded amorphous solid dispersions to enhance solubility and dissolution of poorly water-soluble APIs.

Polymer-Based

Development services for technologically demanding polymer-based delivery systems, handling feasibility screening, polymer excipient sourcing, and complex drug-polymer interactions.

Polymer-Based Dosage Forms

Polymer and extrusion development of delivery systems that can be produced robustly against affordable costs at any scale.

View All Products

Services

Formulation and process development for polymer-based and controlled-release dosage forms, small-scale prototyping, proof-of-concept extrusion and scale-up support for clinical and commercial programs.

Analytical characterization and method development for HME formulations and solid dispersions using microscopy, thermal analysis, spectroscopy, dissolution testing and chromatographic assays.

Regulatory strategy, dossier support and guidance for drug–device combination products, Quality by Design implementation, QTPP, risk assessments and design control documentation for US and EU submissions.

GMP manufacturing including high-containment HPAPI suites, hot melt extrusion at clinical and commercial scale, aseptic fill and finish for syringes, injection molding and assembly/packaging for auto-injectors and rings.

Expertise Areas

  • Controlled-release polymer-based drug delivery
  • High-potency API (HPAPI) development and containment
  • Hot-melt extrusion formulation and scale-up
  • Aseptic sterile manufacturing for high-potent injectables
  • Show More (5)

Key Technologies

  • Hot melt extrusion (HME)
  • Twin-screw extrusion
  • Single-screw extrusion
  • Co-extrusion
  • Show More (12)

News & Updates

Sever Pharma Solutions will participate in BIO International in Boston, MA, USA, from June 16-19, 2025.

The company was acknowledged for its advancements in controlled-release systems and polymer-based drug delivery solutions in the Medicon Valley cluster.

Acknowledged as a key innovator in pharmaceutical manufacturing and research within Medicon Valley.


Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.